Diabetic gastrointestinal autonomic neuropathy: Current status and new achievements for everyday clinical practice

European Journal of Internal Medicine

Volumn 23, Issue 6, 2012, Pages 499-505

  Gatopoulou, A ^a   Papanas, N ^a   Maltezos, E ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Autonomic neuropathy; Diabetes mellitus; Diagnosis; Gastrointestinal system; Gastroparesis; Treatment

Indexed keywords

ACOTIAMIDE; ALOSETRON; ANTIHISTAMINIC AGENT; AZITHROMYCIN; BOTULINUM TOXIN; CAMICINAL; DOMPERIDONE; ERYTHROMYCIN; EXENDIN 4; GABAPENTIN; HERBACEOUS AGENT; IBEROCAST; INSULIN; LAXATIVE; LOPERAMIDE; METOCLOPRAMIDE; NARONAPRIDE; PHENOTHIAZINE DERIVATIVE; PREGABALIN; PROTON PUMP INHIBITOR; PRUCALOPRIDE; RIFAXIMIN; TRAMADOL; ULIMORELIN; UNCLASSIFIED DRUG; VELUSETRAG;

CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL PRACTICE; CONSTIPATION; CONTINUOUS INFUSION; DIABETES MELLITUS; DIABETIC GASTROINTESTINAL AUTONOMIC NEUROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIAGNOSTIC PROCEDURE; DIARRHEA; DIET THERAPY; ELECTROSTIMULATION; ENDOSCOPIC SURGERY; ESOPHAGUS MOTILITY; GASTRECTOMY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT FUNCTION; GLYCEMIC CONTROL; HUMAN; IRRITABLE COLON; ISCHEMIC COLITIS; JEJUNOSTOMY; MESENCHYMAL STEM CELL TRANSPLANTATION; MORBIDITY; NAUSEA; NUTRITIONAL STATUS; PAIN; PATHOGENESIS; POSTOPERATIVE ILEUS; REVIEW; STOMACH EMPTYING; STOMACH PARESIS; TECHNOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 84864611399     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2012.03.001     Document Type: Short Survey

References (87)

1. P. Bytzer, N.J. Talley, M. Leemon, L.J. Young, M.P. Jones, and M. Horowitz Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15000 adults Arch Intern Med 161 2001 1989 1996
2. Y.R. Wang, R.S. Fisher, and H.P. Parkman Gastroparesis-related hospitalizations in the United States: trends, characteristics and outcomes, 1995-2004 Am J Gastroenterol 103 2008 313 322 (Pubitemid 351248745)
3. D. Ziegler Diagnosis and treatment of diabetic autonomic neuropathy Curr Diab Rep 1 2001 216 227
4. P. Kempler, G. Amarenco, R. Freeman, S. Frontoni, M. Horowitz, and M. Stevens Gastrointestinal autonomic neuropathy, erectile-, bladder- and sudomotor dysfunction in patients with diabetes mellitus: clinical impact, assessment, diagnosis, and management Diabetes Metab Res Rev 2011 [Jul 11. Epub ahead of print]
5. J. Tack, and P. Janssen Gastrointestinal motility Curr Opin Gastroenterol 26 2010 647 655
6. M. Camilleri, E. Bharucha, and G. Farrugia Epidemiology, mechanisms and management of diabetic gastroparesis Clin Gastroenterol Hepatol 9 2011 5 12
7. G.N. Verne, and C.A. Snisky Diabetes and the gastrointestinal tract Gastroenterol Clin North Am 27 1998 861 874 (Pubitemid 29023062)
8. M.W. Boehme, F. Autschbach, C. Ell, and U. Raeth Prevalence of silent gastric ulcer, erosions or severe acute gastritis in patients with type 2 diabetes mellitus-a cross-sectional study Hepatogastrenterology 54 2007 643 648 (Pubitemid 46724748)
9. P. Kashyap, and G. Farrugia Diabetic gastroparesis: what we have learned and hand to unlearn in the past 5 years Gut 59 2010 1716 1726
10. H.P. Parkman, W.L. Hasler, and R.S. Fisher American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis Gastroenterology 127 2004 1592 1622 (Pubitemid 39457783)
11. A.E. Bharucha, M. Camillieri, L.A. Forstrom, and A.R. Zinsmeister Relationship between clinical features and gastric emptying disturbances in diabetes mellitus Clin Endocrinol (Oxf) 70 2009 415 420
12. H.K. Jung, R.S. Choung, G.R. Locke 3rd, C.D. Schleck, A.R. Zinsmeister, and L.A. Szarka The incidence, the prevalence and the outcomes of patients with gastroparesis in Olmsted County, Minnesota from 1996 to 2006 Gastroenterology 136 2009 1225 1233
13. M. Horowitz, A.F. Maddox, J.M. Wishart, P.E. Harding, B.E. Chatteron, and D.J. Shearman Relationship between esophageal transit and solid and liquid gastric emptying in diabetes mellitus Eur J Nucl Med 18 1991 229 234
14. F. Kinekawa, F. Kubo, K. Matsuka, M. Kobayashi, Y. Furuta, and H. Okada Esophageal function worsens with long duration of diabetes J Gastroenterol 43 2008 338 344 (Pubitemid 351958897)
15. A. Horikawa, R. Ishii-Nozawa, M. Ohguro, S. Tagagi, M. Ohtuji, and M. Yamada Prevalence of GORD in type 2 diabetes and a comparison of clinical profiles between diabetic patients with and without GORD Diabet Med 26 2009 228 233
16. M. Paragliarulo, F. Fornari, M. Fraguell, M. Zoli, F. Giangregorio, and A. Grigolon Gallstone diseases and related risk factor in a large cohort of diabetic patients Dig Liver Dis 36 2004 130 134 (Pubitemid 41115507)
17. X. Ding, C.Y. Lu, C.A. Liu, and Y.J. Shi Correlation between gene expression of CCK-A receptor and emptying dysfunction of the gallbladder in patients with gallstones and diabetes mellitus Hepatobilliary Panceat Dis Int 4 2005 295 298 (Pubitemid 40790183)
18. A. Nakeeb, A.G. Comuzzie, H. Al Azzawi, G.E. Sonnenberg, A.H. Kisselbach, and H.A. Pitt Insulin resistance causes human gallbladder dysmotility J Gastrointest Surg 10 2006 940 948
19. A.E. Bharucha Fecal incontinence Gastroenterology 124 2003 1672 1685 (Pubitemid 36617685)
20. A. Russo, R. Botten, M.F. Kong, I.M. Chapman, R.J. Fraser, and M. Horowitz Effects of acute hyperglycaemia on anorectal motor and sensory function in diabetes mellitus Diabet Med 21 2004 176 182 (Pubitemid 38221818)
21. L.K. Phillips, C.K. Rayner, K.L. Jones, and M. Horowitz An update on autonomic neuropathy affecting the gastrointestinal tract Curr Diab Rep 6 2006 417 423 (Pubitemid 44896400)
22. M. Chandran, N.V. Chu, and S.V. Edelman Gastrointestinal disturbances in diabetes Curr Diab Rep 3 2003 43 48 (Pubitemid 38906764)
23. S. Rossol Constipation in patients with diabetes mellitus MMW Forschr Med 149 2007 39 42 (Pubitemid 350143938)
24. H.K. Jung, D.Y. Kim, I.H. Moon, and Y.S. Hong Colonic transit time in diabetic patients - comparison with healthy subjects and the effect of autonomic neuropathy Yonsei Med J 44 2003 265 272 (Pubitemid 36592188)
25. J. Lysy, E. Israeli, and E. Goldin The prevalence of chronic diarrhea among diabetic patients Am J Gastroenterol 94 1999 2165 2170 (Pubitemid 29374548)
26. R.C. O'Connor, M.T. Andary, R.B. Russo, and M. DeLano Thoracic radiculopathy Phys Med Rehabil Clin N Am 13 2002 623 644
27. C. Quan, N.J. Talley, M.P. Jones, J. Spies, and M. Horowitz Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow up Am J Gastroentrol 103 2008 2023 2030
28. N. Papanas, A.I. Vinik, and D. Ziegler Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol 7 2011 682 690
29. R. Coleski, and W.L. Hasler Coupling and propagation of normal and dysrhythmic gastric slow waves during acute hyperglycaemia in healthy humans Neurogastroenterol Motil 21 2009 492 499
30. J. Harberson, R.M. Thomas, S.P. Harbison, and H.P. Parkman Gastric neuromuscular pathology in gastroparesis: analysis of full thickness antral biopsies Dig Dis Sci 55 2010 359 370
31. M.M. Selim, G. Wendelschafer-Crabb, J.B. Redmon, A. Khoruts, J.S. Hodges, and K. Koch Gastric mucosal nerve density A biomarker for diabetic autonomic neuropathy? Neurology 75 2010 973 981
32. C. Murray, N.M. Martin, M. Patterson, S.A. Taylor, M.A. Ghatei, and M.A. Kamm Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study Gut 54 2005 1693 1698 (Pubitemid 41697666)
33. H. Bult, C.E. Boeckxstaens, P.A. Pelckmans, F.H. Jordaens, Y.M. Van Maercke, and A.G. Herman Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter Nature 345 1990 346 347
34. T. Takahashi Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract J Gastroenterol 38 2003 421 430 (Pubitemid 36701575)
35. T. Ordog, Y. Hayashi, and J. Gibbons Cellular pathogenesis of diabetic gastroenteropathy Minerva Gastroenterol Dietol 55 2009 315 343
36. A. Mazzone, C.E. Bernard, P.R. Strege, A. Beyder, L.J. Galietta, and P.J. Pasricha Altered expression of Ano variants in human diabetic gastroparesis J Biol Chem 15 2011 13393 13403
37. V.M. Bhor, N. Raghuram, and S. Sivakami Oxidative damage and altered antioxidant enzyme activities in the small intestine of streptozotocine-induced diabetic rats Int J Biochem Cell Biol 36 2004 89 97 (Pubitemid 37338475)
38. Y.K. Samra, M. Wang, N.J. Peat, N.C. Smith, H.R. Shotton, and J. Lincoln Selective susceptibility of different populations of sympathetic neurons to diabetic neuropathy in vivo is reflected by increased vulnerability to oxidative stress in vitro Neurosci Lett 407 2006 199 204 (Pubitemid 44402875)
39. P. Kashyap, and G. Farrugia Oxidative stress: key player in gastrointestinal complications of diabetes Neurogastroenterol Motil 23 2011 111 114
40. K.M. Choi, S.J. Gibbons, T.V. Nguyen, G.J. Stoltz, M.S. Lurken, and T. Ordog Hemeoxygenase-1 protects interstitial cellsof Cajal from oxidative stress and reverses diabetic gastroparesis Gastroenterology 135 2008 2055 2064
41. P. Kashyap, and G. Farrugia Enteric autoantibodies and gut motility disorders Gastroenterol Clin North Am 37 2008 397 410 (Pubitemid 351680536)
42. H. Bour-Jordan, and J.A. Bluestone Sensory neurons link the nervous system ans autoimmune diabetes Cell 127 2006 1097 1099 (Pubitemid 44894530)
43. I. Gutierrez-Canas, Y. Juarranz, B. Santiago, A. Arranz, C. Martinez, and M. Galindo VIP down-regulates TLR4 expression and TLR4-Mediated chemokine production in human rheumatoid synovial fibroblasts Rheumatology (Oxford) 45 2006 527 532
44. B. Chandrasekharan, and S. Srinivasan Diabetes and the enteric nervous system Neurogastroentrol Motil 19 2007 951 960 (Pubitemid 350198313)
45. F.R. Coulson, D.B. Jacoby, and A.D. Fryer Insulin regulates neuronal M2 muscarinic receptor function in the ileum of diabetic rats J Pharmacol Exp Ther 308 2004 760 766 (Pubitemid 38134241)
46. V.J. Horvath, H. Vittal, A. Lörincz, H. Chen, G. Almeida-Porada, and D. Redelman Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis Gastroenterology 130 2006 759 770 (Pubitemid 43374526)
47. R.E. Schmidt, D.A. Dorsey, L.N. Beaudet, S.B. Plurad, C.A. Parvin, and S. Ohara Effect of IGF-I and neurotrophin-e on gracile neuroaxonal dystrophy in diabetic and aging rats Brain Res 876 2000 88 94
48. K.V. Gaddipati, H.P. Simonian, K.M. Kresge, G.H. Boden, and H.P. Parkman Abnormal ghrelin and pancreatic polyptetide responses in gastroparesis Dig Dis Sci 51 2006 1339 1346 (Pubitemid 44315799)
49. G. Tougas, R.H. Hunt, D. Fitzpatrick, and A.R. Upton Evidence of impaired afferent vagal function in patients with diabetes gastroparesis Pacing Clin Electrophysiol 15 1992 1597 1602
50. J.B. Frokjaer, L.L. Egsgaard, C. Graversen, E. Softeland, G. Dimcevski, and R.A. Blauenfeldt Gastrointestinal symptoms in type-1: is it all about brain plasticity? Eur J Pain 15 2011 249 257
51. J. Tack, N.J. Talley, M. Camilleri, G. Holtmann, P. Hu, and J.R. Malagelada Functional gastroduodenal disorders Gastroenterology 130 2006 1466 1479
52. A. Patric, and O. Epstein Review article: gastroparesis Aliment Pharmacol Ther 27 2008 724 740 (Pubitemid 351492477)
53. T.L. Abell, M. Camillieri, K. Donohoe, W.L. Hasler, H.C. Lin, and A.H. Maurer Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine Am J Gastroenterol 103 2008 753 763 (Pubitemid 351405987)
54. L.A. Szarka, M. Camilleri, A. Vella, D. Burton, K. Baxter, and J. Simonson A stable isotope breath test with standard meal for abnormal gastric emptying of solids in the clinic and in research Clin Gastroenterol Hepatol 6 2008 635 643
55. L. Szarka, and M. Camillieri Stomach dysfunction in diabetes mellitus: emerging technology and pharmacology J Diabetes Sci Technol 4 2010 180 189
56. D. Cassilly, S. Kantor, L.C. Knight, A.H. Maurer, R.S. Fisher, and J. Semler Gastric emptying of a non-digestible solid: assessment with simultaneous Smart Pill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy Neurogastroenterol Motil 20 2008 311 319 (Pubitemid 351441734)
57. B. Kuo, R.W. McCallum, K.L. Koch, M.D. Sitrin, J.M. Wo, and W.D. Chey Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects Aliment Pharmacol Ther 27 2008 186 196 (Pubitemid 350256610)
58. D. Bilecen, K. Scheffler, E. Seifritz, G. Bongartz, and W. Steinbrich Hydro-MRI for the visualization of gastri wall motility using RARE magnetic resonance imaging sequences Abdom Imaging 25 2000 30 34 (Pubitemid 30033442)
59. E.P. Bouras, S. Delgado-Aros, M. Camilleri, E.J. Castillo, D.D. Burton, and G.M. Thomforde SPECT imaging of the stomach: comparison with barostat and effects of sex, age, body mass index and fundoplication Sigle photon emission computed tomography Gut 51 2002 781 786
60. D. Liao, H. Gregersen, T. Hausken, O.H. Gilja, M. Mundt, and G. Kassab Analysis of surface geometry of the human stomach using real-time 3-D ultrasonography in vivo Neurogastroenterol Motil 16 2004 315 324 (Pubitemid 38869655)
61. J.A. Wilson, and M.F. Vela New esophageal function testing (impedance, Bravo pH monitoring and high-resolution manometry): clinical relevance Curr Gastroenterol Rep 10 2008 222 230
62. C. Quan, N.J. Talley, S. Cross, M. Jones, J. Hammer, and N. Giles Development and validation of the Diabetes Bowel Symptom Questionnaire Aliment Pharmacol Ther 17 2003 1179 1187 (Pubitemid 36605755)
63. D.A. Revicki, A.M. Rentz, D. Dubois, P. Kahrilas, V. Stanghellini, and N.J. Talley Development and validation of a patient-assessed gastroparesis symptom severity measure; the Gastroparesis Cardinal Symptom Index Aliment Pharmacol Ther 18 2003 141 150 (Pubitemid 36897991)
64. H.P. Parkman, K.P. Yates, W.L. Hasler, L. Nguyan, P.J. Pasricha, and W.J. Snape Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis Gastroenterology 142 2011 486 498
65. J. Tack Prokinetics and fundic relaxants in upper functional GI disorders Curr Opin Pharmacol 8 2008 690 696
66. D. Patterson, T. Abell, R. Rothstein, K. Koch, and J. Barnett A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis Am J Gastroenterol 94 1999 1230 1234 (Pubitemid 29214634)
67. R. Dhir, and J.E. Richter Erythromycin in the short- and long term control of dyspepsia symptoms in patients with gastroparesis J Clin Gastroenterol 38 2004 237 242 (Pubitemid 38233331)
68. D. Sharma, G. Morrison, F. Joseph, T.S. Purewal, and P.J. Weston The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis Diabetologia 54 2011 2768 2770
69. M. Camilleri, R. Kerstens, and G. Beyens A double-blind, placebo-controlled trial to evaluate the safety and tolerability of prucalopride oral solution in constipated elderly patients living in a nursing facility Gastroenterology 136 2009 240 [Abstract]
70. G.J. Sanger, S.M. Westaway, A.A. Barnes, D.T. Macpherson, A.I. Muir, and E.M. Jarvie GSK962040 a small molecule selective motilin agonist, effective as a stimulant of human and rabbit gastrointestinal motility Neurogastroenterol Motil 21 2009 657 664
71. N. Ejskaer, G. Dimcevski, J. Wo, P.M. Hellström, L.C. Gormsen, and I. Sarosiek Safety and efficacy of ghrelin agonist TZP-101, in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study Neurogastroenterol Motil 22 2010 1069-e281
72. B. Braden, W. Caspary, N. Borner, B. Vinson, and A.R. Schneider Clinical effects of STW5 [Iberocast] are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis Neurogastroenterol Motil 21 2009 632 638
73. Y. Bai, M.J. Xu, X. Yang, C. Xu, J. Gao, and D.W. Zou A systematic review on intrapyloric botulinum toxin injection for gastroparesis Digestion 81 2010 27 34
74. R.W. McCallum, W. Snape, F. Brady, J. Wa, H.P. Parkman, and T. Nowak Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study Clin Gastroenterol Hepatol 8 2010 947 954
75. S.R. Daram, S.J. Tang, and T.L. Abell Temporary gastric electrical stimulation for gastroparesis: endoscopic placement of electrodes [ENDOstim] Surg Endosc 25 2011 3444 3445
76. H. Chu, Z. Lin, L. Zhong, R.W. McCallum, and X. Hou A meta-analysis: the treatment of high-frequency gastric electrical stimulation for gastroparesis J Gastroenterol Hepatol 2011 [Dec 1 Epub ahead of print]
77. Z. Lin, I. Sarosiek, J. Forster, R.A. Ross, J.D. Chen, and R.W. McCallum Two-channel gastric pacing in patients with diabetic gastroparesis Neurogastroenterol Motil 23 2011 912-e396
78. A.E. Bharucha, M. Camilleri, L.A. Forstrom, and A.R. Zinsmeister Relationship between clinical features and gastric emptying disturbances in diabetes mellitus Clin Endocrinol 70 2009 415 420
79. H. Linnebjerg, S. Park, P.A. Kothare, M.E. Trautmann, K. Mace, and M. Fineman Effect of exenatide on gastric emptying and relationship to postpradial glycemia in type 2 diabetes Regul Pept 151 2008 123 129
80. B. Zietz, G. Lock, R.H. Straub, B. Braun, J. Schölmerich, and K.D. Palitzsch Small-bowel bacterial overgrowth in diabetic subject is associated with cardiovascular autonomic neuropathy Diabetes Care 23 2000 1200 1201 (Pubitemid 30616816)
81. J. Bures, J. Cyrany, D. Kohoutova, M. Förstl, S. Rejchrt, and J. Kvetina Small intestinal bacterial overgrowth syndrome World J Gastroenterol 16 2010 2978 2990
82. M. Pimentel Review of rifaximine as treatment for small intestinal bacterial overgrowth and irritable bowel syndrome Expert Opin Investig Drugs 18 2009 349 358
83. M. Samson, and M. Verhagen Intestinal function M. Horowitz, M. Samson, Gastrointestinal function in diabetes mellitus 2004 John Wiley and Sons Chichester 177 217
84. G. Sanger, and D. Alpers Development of drugs for gastrointestinal motor disorders: translating science to clinical need Neurogastroenterol Motil 20 2008 177 184 (Pubitemid 351197401)
85. M. Camilleri Novel pharmacology: asimadoline, a kappa-opiod agonist and visceral sensation Neurogastroenterol Motil 20 2008 971 979
86. D.M. Tang, and F.K. Fridernberg Gastroparesis: approach, diagnostic evaluation and management Dis Mon 57 2011 74 101
87. V. Volarevic, N. Arsenijevic, M.L. Lukic, and M. Stojkovic Concise review Mesenchymal stem cell treatment of the complications of diabetes mellitus Stem Cells 29 2011 5 10